Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Arnaud Quillent"'
Autor:
Samy Ammari, Raoul Sallé de Chou, Corinne Balleyguier, Emilie Chouzenoux, Mehdi Touat, Arnaud Quillent, Sarah Dumont, Sophie Bockel, Gabriel C. T. E. Garcia, Mickael Elhaik, Bidault Francois, Valentin Borget, Nathalie Lassau, Mohamed Khettab, Tarek Assi
Publikováno v:
Diagnostics, Vol 11, Iss 11, p 2043 (2021)
Glioblastoma (GBM) is the most common and aggressive primary brain tumor in adult patients with a median survival of around one year. Prediction of survival outcomes in GBM patients could represent a huge step in treatment personalization. The object
Externí odkaz:
https://doaj.org/article/3428d18c49c14d4880c655f172cab863
Autor:
Samy Ammari, Raoul Sallé de Chou, Tarek Assi, Mehdi Touat, Emilie Chouzenoux, Arnaud Quillent, Elaine Limkin, Laurent Dercle, Joya Hadchiti, Mickael Elhaik, Salma Moalla, Mohamed Khettab, Corinne Balleyguier, Nathalie Lassau, Sarah Dumont, Cristina Smolenschi
Publikováno v:
Diagnostics, Vol 11, Iss 7, p 1263 (2021)
Anti-angiogenic therapy with bevacizumab is a widely used therapeutic option for recurrent glioblastoma (GBM). Nevertheless, the therapeutic response remains highly heterogeneous among GBM patients with discordant outcomes. Recent data have shown tha
Externí odkaz:
https://doaj.org/article/429e35dc49b54b0099d29cf4b9a4fda7
Autor:
Yingping Li, Samy Ammari, Littisha Lawrance, Arnaud Quillent, Tarek Assi, Nathalie Lassau, Emilie Chouzenoux
Publikováno v:
Cancers
Cancers, 2022, 14 (7), pp.1778. ⟨10.3390/cancers14071778⟩
Cancers; Volume 14; Issue 7; Pages: 1778
Cancers, 2022, 14 (7), pp.1778. ⟨10.3390/cancers14071778⟩
Cancers; Volume 14; Issue 7; Pages: 1778
Gliomas are among the most common types of central nervous system (CNS) tumors. A prompt diagnosis of the glioma subtype is crucial to estimate the prognosis and personalize the treatment strategy. The objective of this study was to develop a radiomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abd79aea9ea830e04ff71f51fa429556
https://hal.science/hal-03647258/file/Cancers_1638733(Last_submitted_version).pdf
https://hal.science/hal-03647258/file/Cancers_1638733(Last_submitted_version).pdf
Autor:
Mickael Elhaik, Laurent Dercle, Emilie Chouzenoux, Mehdi Touat, Salma Moalla, Joya Hadchiti, Sarah Dumont, Arnaud Quillent, Nathalie Lassau, Raoul Sallé de Chou, Cristina Smolenschi, Samy Ammari, Mohamed Khettab, Tarek Assi, Corinne Balleyguier, Elaine Johanna Limkin
Publikováno v:
Diagnostics
Diagnostics, MDPI, 2021, 11 (7), pp.1263. ⟨10.3390/diagnostics11071263⟩
Diagnostics, 2021, 11 (7), pp.1263. ⟨10.3390/diagnostics11071263⟩
Diagnostics; Volume 11; Issue 7; Pages: 1263
Diagnostics, Vol 11, Iss 1263, p 1263 (2021)
Diagnostics, MDPI, 2021, 11 (7), pp.1263. ⟨10.3390/diagnostics11071263⟩
Diagnostics, 2021, 11 (7), pp.1263. ⟨10.3390/diagnostics11071263⟩
Diagnostics; Volume 11; Issue 7; Pages: 1263
Diagnostics, Vol 11, Iss 1263, p 1263 (2021)
International audience; Anti-angiogenic therapy with bevacizumab is a widely used therapeutic option for recurrent glioblastoma (GBM). Nevertheless, the therapeutic response remains highly heterogeneous among GBM patients with discordant outcomes. Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8d4ba7ef9c75e41df233787a5502eb2
https://hal.sorbonne-universite.fr/hal-03292019
https://hal.sorbonne-universite.fr/hal-03292019
Autor:
Emilie Chouzenoux, Raoul Sallé de Chou, Nathalie Lassau, Samy Ammari, Corinne Balleyguier, Mickael Elhaik, Arnaud Quillent
Publikováno v:
Journal of Neuroradiology. 48:225-226
Objectifs Le but de cette etude est d’etudier les performances de l’analyse radiomique IRM dans le cadre du diagnostic des tumeurs des glandes parotides utilisant des methodes d’apprentissage automatique (machine learning). Nous evaluerons egal
Autor:
Mickael Elhaik, Corine Balleyguier, Arnaud Quillent, Samy Ammari, Emilie Chouzenoux, Raoul Sallé de Chou, Nathalie Lassau
Publikováno v:
Journal of Neuroradiology. 48:224
Le glioblastome est le type de tumeur cerebrale primaire la plus agressive chez l’adulte avec un mauvais pronostic. L’anti angiogenique avec le bevacizumab, est actuellement le traitement le plus utilise pour la prise en charge des glioblastomes